Annual EBITDA
-$39.50 M
-$11.27 M-39.94%
December 1, 2023
Summary
- As of February 7, 2025, RVPH annual EBITDA is -$39.50 million, with the most recent change of -$11.27 million (-39.94%) on December 1, 2023.
- During the last 3 years, RVPH annual EBITDA has fallen by -$37.17 million (-1596.23%).
- RVPH annual EBITDA is now -10406.28% below its all-time high of -$376.00 thousand, reached on December 31, 2019.
Performance
RVPH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$8.36 M
-$513.30 K-6.54%
September 1, 2024
Summary
- As of February 7, 2025, RVPH quarterly EBITDA is -$8.36 million, with the most recent change of -$513.30 thousand (-6.54%) on September 1, 2024.
- Over the past year, RVPH quarterly EBITDA has increased by +$2.97 million (+26.19%).
- RVPH quarterly EBITDA is now -2275.20% below its all-time high of -$352.00 thousand, reached on November 1, 2020.
Performance
RVPH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$33.27 M
+$2.97 M+8.19%
September 1, 2024
Summary
- As of February 7, 2025, RVPH TTM EBITDA is -$33.27 million, with the most recent change of +$2.97 million (+8.19%) on September 1, 2024.
- Over the past year, RVPH TTM EBITDA has increased by +$8.61 million (+20.55%).
- RVPH TTM EBITDA is now -5282.75% below its all-time high of -$618.10 thousand, reached on March 31, 2020.
Performance
RVPH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RVPH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.9% | +26.2% | +20.6% |
| 3 y3 years | -1596.2% | +28.5% | +2.3% |
| 5 y5 years | -10000.0% | +28.5% | +2.3% |
RVPH EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -364.0% | at low | -138.0% | +30.4% | -252.6% | +20.6% |
| 5 y | 5-year | <-9999.0% | at low | -2275.2% | +30.4% | -5282.8% | +20.6% |
| alltime | all time | <-9999.0% | at low | -2275.2% | +30.4% | -5282.8% | +20.6% |
Reviva Pharmaceuticals Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.36 M(+6.5%) | -$33.27 M(-8.2%) |
| Jun 2024 | - | -$7.85 M(+5.7%) | -$36.24 M(-9.6%) |
| Mar 2024 | - | -$7.42 M(-23.0%) | -$40.08 M(+1.5%) |
| Dec 2023 | -$39.50 M(+39.9%) | -$9.64 M(-14.9%) | -$39.50 M(-5.7%) |
| Sep 2023 | - | -$11.33 M(-3.1%) | -$41.88 M(+22.9%) |
| Jun 2023 | - | -$11.69 M(+70.9%) | -$34.06 M(+22.9%) |
| Mar 2023 | - | -$6.84 M(-43.1%) | -$27.71 M(-1.8%) |
| Dec 2022 | -$28.23 M | -$12.02 M(+242.1%) | -$28.23 M(+41.9%) |
| Sep 2022 | - | -$3.51 M(-34.1%) | -$19.90 M(+6.6%) |
| Jun 2022 | - | -$5.33 M(-27.5%) | -$18.66 M(+25.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$7.36 M(+99.7%) | -$14.93 M(+58.2%) |
| Dec 2021 | -$8.51 M(+265.6%) | -$3.69 M(+61.9%) | -$9.44 M(+52.3%) |
| Sep 2021 | - | -$2.28 M(+42.2%) | -$6.20 M(+29.5%) |
| Jun 2021 | - | -$1.60 M(-14.5%) | -$4.78 M(+21.6%) |
| Mar 2021 | - | -$1.87 M(+319.4%) | -$3.93 M(+46.8%) |
| Dec 2020 | -$2.33 M(+519.4%) | -$446.40 K(+26.8%) | -$2.68 M(+20.0%) |
| Nov 2020 | - | -$352.00 K(-31.3%) | -$2.23 M(+18.7%) |
| Sep 2020 | - | -$512.10 K(-31.9%) | -$1.88 M(+37.4%) |
| Jun 2020 | - | -$752.20 K(+21.7%) | -$1.37 M(+121.7%) |
| Mar 2020 | - | -$618.10 K | -$618.10 K |
| Dec 2019 | -$376.00 K | - | - |
FAQ
- What is Reviva Pharmaceuticals Holdings annual EBITDA?
- What is the all time high annual EBITDA for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings annual EBITDA year-on-year change?
- What is Reviva Pharmaceuticals Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly EBITDA year-on-year change?
- What is Reviva Pharmaceuticals Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings TTM EBITDA year-on-year change?
What is Reviva Pharmaceuticals Holdings annual EBITDA?
The current annual EBITDA of RVPH is -$39.50 M
What is the all time high annual EBITDA for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high annual EBITDA is -$376.00 K
What is Reviva Pharmaceuticals Holdings annual EBITDA year-on-year change?
Over the past year, RVPH annual EBITDA has changed by -$11.27 M (-39.94%)
What is Reviva Pharmaceuticals Holdings quarterly EBITDA?
The current quarterly EBITDA of RVPH is -$8.36 M
What is the all time high quarterly EBITDA for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high quarterly EBITDA is -$352.00 K
What is Reviva Pharmaceuticals Holdings quarterly EBITDA year-on-year change?
Over the past year, RVPH quarterly EBITDA has changed by +$2.97 M (+26.19%)
What is Reviva Pharmaceuticals Holdings TTM EBITDA?
The current TTM EBITDA of RVPH is -$33.27 M
What is the all time high TTM EBITDA for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high TTM EBITDA is -$618.10 K
What is Reviva Pharmaceuticals Holdings TTM EBITDA year-on-year change?
Over the past year, RVPH TTM EBITDA has changed by +$8.61 M (+20.55%)